Evidence map›Paper›PMID 26118833›Full record

ArticleDrug and alcohol dependence2015

Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.

M L Miller, S M Aarde, A Y Moreno, K M Creehan, K D Janda, M A Taffe

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Lasting effects of repeated ∆British journal of pharmacology · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M L MillerCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
S M AardeCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
A Y MorenoDepartments of Chemistry, Immunology and Microbial Science, Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USA.
K M CreehanCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.
K D JandaDepartments of Chemistry, Immunology and Microbial Science, Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USA.
M A TaffeCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA. Electronic address: mtaffe@scripps.edu.

Funding

Immunopharmacotherapy for Methamphetamine AddictionR01DA024705 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAFFE, MICHAEL A. · 2008 to 2018
$4.4M
NIDA NIH HHS DA024705NIDA NIH HHS R01 DA024705
6 · The paper itself

Abstract

backgroundd-Methamphetamine (METH) addiction is a serious public health concern for which successful treatment remains elusive. Immunopharmacotherapy has been shown to attenuate locomotor and thermoregulatory effects of METH. The current study investigated whether active vaccination against METH could alter intravenous METH self-administration in rats.

methodsMale Sprague-Dawley rats (Experiment 1: N=24; Experiment 2: N=18) were vaccinated with either a control keyhole-limpet hemocyanin conjugate vaccine (KLH) or a candidate anti-METH vaccine (MH6-KLH) or. Effects of vaccination on the acquisition of METH self-administration under two dose conditions (0.05, 0.1mg/kg/inf) and post-acquisition dose-substitution (0, 0.01, 0.05, 0.20mg/kg/inf, Experiment 1; 0.01, 0.05, 0.10, 0.15mg/kg/inf, Experiment 2) during steady-state responding were investigated. Plasma METH concentrations were determined 30min after an acute challenge dose of 3.2mg/kg METH.

resultsActive vaccination inhibited the acquisition of METH self-administration under the 0.1mg/kg/inf dose condition, with 66% of the MH6-KLH-vaccinated rats compared to 100% of the controls reaching criteria, and produced transient and dose-dependent effects on self-administration during the maintenance phase. Under the 0.05mg/kg/inf dose condition, MH6-KLH-vaccinated rats initially self-administered more METH than controls, but then self-administration decreased across the acquisition phase relative to controls; a subsequent dose-response assessment confirmed that MH6-KLH-vaccinated rats failed to acquire METH self-administration. Finally, plasma METH concentrations were higher in MH6-KLH-vaccinated rats compared to controls after an acute METH challenge, and these were positively correlated with antibody titers.

conclusionsThese data demonstrate that active immunopharmacotherapy for METH attenuates the acquisition of METH self-administration.

Indexed as

AnimalsBehavior, AddictiveDose-Response Relationship, DrugHemocyaninsInfusions, IntravenousMaleMethamphetamineRatsRats, Sprague-DawleySelf AdministrationTreatment OutcomeVaccinationVaccinesHemocyaninskeyhole-limpet hemocyaninMethamphetamineVaccinesActive vaccinationDrug addictionImmunopharmacotherapyMethamphetamineSelf-administration

Identifiers

PMID26118833
PMCPMC4509945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.